(Last updated : 2025-09-08 15:03:32)
  NEMOTO Yuuki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Research Associate
■ Published papers
1. Original article  Impact of polypharmacy on perioperative outcomes of robot‐assisted laparoscopic partial nephrectomy for small renal masses. 2025/09
2. Original article  Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma. 2025/08
3. Other  Comparison of clinical outcomes between cabozantinib+nivolumab and lenvatinib+pembrolizumab in advanced renal cell carcinoma. 2025/05 Link
4. Other  Impact of cytoreductive nephrectomy on immune checkpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies for metastatic renal cell carcinoma with primary kidney tumors. 2025/05 Link
5. Other  Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. 2025/05 Link
Display all(29)
■ Academic conference presentation
1. Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. (ポスター掲示,一般) 2025/04/29
2. Comparison of clinical outcomes between cabozantinib+nivolumab and lenvatinib+pembrolizumab in advanced renal cell carcinoma. (ポスター掲示,一般) 2025/04/28
3. Impact of cytoreductive nephrectomy on immunecheckpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies formetastatic renal cell carcinoma with primary kidneytumors. (ポスター掲示,一般) 2025/04/28
4. Impact of corticosteroid administration on treatment effectiveness in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor-based combination therapy. (ポスター掲示,一般) 2024/05/03
5. Impact of gender on the efficacy of immune checkpoint inhibitor therapy in renal cell carcinoma. (ポスター掲示) 2024/04/27
Display all(19)